TAKE THIS POLL |
|
|
- Recurring Symptoms Experienced By Nearly 40 Percent Of GERD Patients Taking PPIs 17 May 2008 08:08 GMT
... 16,000 members include physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver. The AGA, a 501(c6) organization, administers all membership and public policy ...
- Complete Information on Blue rubber bleb nevus 17 May 2008 07:37 GMT
... syndrome is a rare disorder that consists mainly of abnormal blood vessels affecting the gastrointestinal tract. It is even a rare cause of gastrointestinal hemorrhage during childhood. Blue rubber ...
- Give Us Our Daily Meds 17 May 2008 07:33 GMT
... In addition, there is the pharmaceutical industry's relentless advertising. With ... for Type 2 diabetes, sleeping troubles and gastrointestinal problems such as heartburn. Copyright 2008 Associated ...
- $30 Million Hospital For Majuro? 17 May 2008 06:36 GMT
... Majuro — A plan to build a $30 million hospital ... many Marshall Islanders migrate to America, increasing gastrointestinal problems from water-borne illnesses, the highest teen ...
- New Pfizer Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at ASCO 17 May 2008 05:46 GMT
... New Pfizer Data in Lung Cancer, Ewing's Sarcoma, Prostate Cancer and ... of advanced renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST) after disease progression on ...
- Three Month Results Reported from Stem & Regenerative Cell Breast Augmentation Study 17 May 2008 05:40 GMT
... Three Month Results Reported from Stem & Regenerative Cell Breast ... disease and planned for spinal disc degeneration, gastrointestinal disorders, and other unmet medical needs. www.cytoritx.com ...
- Latest research on GI health presented at DDW 2008 17 May 2008 05:16 GMT
... Latest research on GI health presented at DDW 2008 Colonoscopy: ... real-time microscopic technique could change the way gastrointestinal diseases are detected -- confocal laser endomicroscopy ...
- Researchers Uncover Protein Associated with Gleevec-Resistant Tumors 17 May 2008 05:16 GMT
... Researchers Uncover Protein Associated with Gleevec-Resistant Tumors Excess amounts ... a protein called IGF-1R in patients with gastrointestinal stromal tumors (GISTs) could indicate that the ...
- Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 17 May 2008 04:41 GMT
... Alba Therapeutics Announces the Enrollment and Randomization of the ... system, or through inhibitory, direct effects on gastrointestinal associated lymphoid tissue. Larazotide acetate is orally ...
- ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 17 May 2008 04:41 GMT
... ASCO Study Confirms Importance of Histology in Treatment of Non-Small ... closely for toxicity, especially myelosuppression, renal and gastrointestinal toxicities. It is recommended that nursing be ...
- Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 17 May 2008 04:41 GMT
... Strength and Innovation of Novartis Oncology Products and Pipeline With ... cancer, organ transplantation, central nervous system, dermatological, gastrointestinal and respiratory areas. The company's mission is ...
- New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 17 May 2008 04:41 GMT
... New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) ... observed throughout therapy, cardiac and pulmonary disorders, gastrointestinal adverse events, thrombocytopenia, neutropenia and tumor lysis ...
- Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies 17 May 2008 04:41 GMT
... Wyeth's Pristiq, a New Treatment for Major Depressive Disorder ... areas of women's health care, infectious disease, gastrointestinal health, central nervous system, inflammation, transplantation, hemophilia, ...
- Newcomb: Spirit-breaking: Mission horrors 17 May 2008 04:39 GMT
... In 1769, Catholic priest Junipero Serra founded the Catholic mission ... more perfect arrangement for the spread of gastrointestinal disorders could scarcely be devised,'' said one ...
- CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients 17 May 2008 04:35 GMT
... CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer ... (reflective of how OM affects diet, swallowing, gastrointestinal function and quality of life) of Grades ...
- Salix Pharmaceuticals Receives Approvable Letter from FDA for Balsalazide Tablet 17 May 2008 00:54 GMT
... today announced that the Company has received an approvable letter ... prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage ...
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Thera 16 May 2008 16:51 GMT
... fat soluble vitamin deficiencies. Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders. Welchol reduces gastrointestinal ...
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly 16 May 2008 16:41 GMT
... fat soluble vitamin deficiencies. Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders. Welchol reduces gastrointestinal ...
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lo 16 May 2008 16:41 GMT
... fat soluble vitamin deficiencies. Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders. Welchol reduces gastrointestinal ...
- Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes 16 May 2008 13:34 GMT
... fat soluble vitamin deficiencies. Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders. Welchol reduces gastrointestinal ...
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based The 16 May 2008 13:33 GMT
... fat soluble vitamin deficiencies. Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders. Welchol reduces gastrointestinal ...
- Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With Type 2 Diabetes 16 May 2008 13:31 GMT
... fat soluble vitamin deficiencies. Caution should also be exercised when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with dysphagia and swallowing disorders. Welchol reduces gastrointestinal ...
- The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abstract Posted Online a 16 May 2008 11:29 GMT
... Company, Inc., a privately held developer of gastrointestinal therapeutics, today reported that the American Society ... found primarily on mucosal surfaces throughout the gastrointestinal tract, including the mouth, esophagus and intestines, ...
- The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abst 16 May 2008 10:46 GMT
... Company, Inc., a privately held developer of gastrointestinal therapeutics, today reported that the American Society ... found primarily on mucosal surfaces throughout the gastrointestinal tract, including the mouth, esophagus and intestines, ...
- The GI Company Reports Significant Reduction in Occurrence of Oral Mucositis in Phase II Study; Abstract Posted Online at ASCO.org 16 May 2008 10:35 GMT
... Company, Inc., a privately held developer of gastrointestinal therapeutics, today reported that the American Society ... found primarily on mucosal surfaces throughout the gastrointestinal tract, including the mouth, esophagus and intestines, ...
1 - 25 of 917 next >
News by PR Newswire
|
